CA2069594A1 - Virus de l'avipox recombinant, culture de cellules infrectees par ce virus et vaccins pour la volaille derives de ce virus - Google Patents

Virus de l'avipox recombinant, culture de cellules infrectees par ce virus et vaccins pour la volaille derives de ce virus

Info

Publication number
CA2069594A1
CA2069594A1 CA002069594A CA2069594A CA2069594A1 CA 2069594 A1 CA2069594 A1 CA 2069594A1 CA 002069594 A CA002069594 A CA 002069594A CA 2069594 A CA2069594 A CA 2069594A CA 2069594 A1 CA2069594 A1 CA 2069594A1
Authority
CA
Canada
Prior art keywords
virus
recombinant
sequence
protein
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002069594A
Other languages
English (en)
French (fr)
Inventor
Georges Thiry
Didier Colau
Catherine De Wannemaeker
Daniel Malarme
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dimminaco AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2069594A1 publication Critical patent/CA2069594A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455Eimeria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24041Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CA002069594A 1991-05-27 1992-05-26 Virus de l'avipox recombinant, culture de cellules infrectees par ce virus et vaccins pour la volaille derives de ce virus Abandoned CA2069594A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE09100507 1991-05-27
BE9100507A BE1004877A3 (fr) 1991-05-27 1991-05-27 Virus de l'avipox recombinant, culture de cellules infectees par ce virus et vaccins pour la volaille derives de ce virus.

Publications (1)

Publication Number Publication Date
CA2069594A1 true CA2069594A1 (fr) 1992-11-28

Family

ID=3885526

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002069594A Abandoned CA2069594A1 (fr) 1991-05-27 1992-05-26 Virus de l'avipox recombinant, culture de cellules infrectees par ce virus et vaccins pour la volaille derives de ce virus

Country Status (23)

Country Link
EP (1) EP0517292B1 (enExample)
JP (1) JP3411307B2 (enExample)
KR (1) KR100244601B1 (enExample)
CN (1) CN1055501C (enExample)
AR (1) AR248045A1 (enExample)
AT (1) ATE189480T1 (enExample)
AU (1) AU656185B2 (enExample)
BE (1) BE1004877A3 (enExample)
BR (1) BR9202024A (enExample)
CA (1) CA2069594A1 (enExample)
DE (1) DE69230627T2 (enExample)
DK (1) DK0517292T3 (enExample)
ES (1) ES2145000T3 (enExample)
HU (1) HU215531B (enExample)
IE (1) IE921686A1 (enExample)
IL (1) IL101780A (enExample)
MX (1) MX9202512A (enExample)
NZ (1) NZ242620A (enExample)
PT (1) PT517292E (enExample)
RU (1) RU2130971C1 (enExample)
SG (1) SG49876A1 (enExample)
TW (1) TW288048B (enExample)
ZA (1) ZA923321B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2110505A1 (en) * 1991-07-26 1993-02-18 Enzo Paoletti Infectious bursal disease virus recombinant poxvirus vaccine
ATE286137T1 (de) * 1992-01-13 2005-01-15 Virogenetics Corp Rekombinantes vaccinia-virus als impfstoff gegen das marek-virus
FR2697534A1 (fr) * 1992-11-02 1994-05-06 Rhone Merieux Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu.
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
AU6299594A (en) * 1993-02-26 1994-09-14 Nippon Zeon Co., Ltd. Recombinant fowlpox virus s-fpv-043 and uses thereof
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
GB9711957D0 (en) 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
US7041439B2 (en) * 2001-04-17 2006-05-09 Embrex, Inc. Methods and apparatus for selectively processing eggs having identified characteristics
GB0118532D0 (en) 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
EP1450854A2 (en) 2001-11-30 2004-09-01 Isis Innovation Limited Vaccine
PL216760B1 (pl) * 2002-05-16 2014-05-30 Bavarian Nordic As Rekombinowany modyfikowany wirus krowianki Ankara oraz sposób jego otrzymywania i zastosowania
EP1601333B1 (en) * 2003-02-20 2013-01-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Novel insertion sites in pox vectors
GB2402391A (en) * 2003-06-04 2004-12-08 Oxxon Pharmaccines Ltd Fowlpox recombinant genome
EP2785373B1 (en) 2011-11-30 2019-11-20 Boehringer Ingelheim Animal Health USA Inc. Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
EP2845904A1 (en) 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
EP3050572A1 (en) 2015-01-29 2016-08-03 Ceva Sante Animale Recombinant MDV1 and the uses thereof
EP3263129A1 (en) 2016-06-29 2018-01-03 Ceva Sante Animale Duck enteritis virus and the uses thereof
CN117357642A (zh) 2016-12-14 2024-01-09 勃林格殷格翰动物保健美国公司 表达禽病原体的多种抗原的重组hvt载体及其用途
CN113347992A (zh) 2018-12-27 2021-09-03 法国诗华大药厂 重组病毒和其用途
MA58717A1 (fr) 2020-06-17 2023-06-28 Boehringer Ingelheim Vetmedica Gmbh Vecteurs hvt recombinants exprimant l'hémagglutinine de la grippe et compositions immunogènes, et leur fabrication et leurs utilisations
TWI812936B (zh) 2021-04-01 2023-08-21 智勝科技股份有限公司 研磨墊及研磨方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
FR2632863B2 (fr) * 1987-10-29 1990-08-31 Transgene Sa Virus du fowlpox recombinant et vaccins derives de ces virus
US5310671A (en) * 1988-06-24 1994-05-10 British Technology Group Limited Fowlpox virus non-essential regions
US5093258A (en) * 1988-08-26 1992-03-03 Therion Biologics Corporation Recombinant fowlpox virus and recombination vector
AU623476B2 (en) * 1988-12-29 1992-05-14 Nippon Zeon Co., Ltd. Promoter, plasmid containing the same, and recombinant avipoxvirus
AU643216B2 (en) * 1989-05-30 1993-11-11 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form

Also Published As

Publication number Publication date
ZA923321B (en) 1993-01-27
EP0517292A1 (fr) 1992-12-09
HUT62331A (en) 1993-04-28
AU656185B2 (en) 1995-01-27
IL101780A (en) 2000-12-06
ATE189480T1 (de) 2000-02-15
RU2130971C1 (ru) 1999-05-27
TW288048B (enExample) 1996-10-11
HU215531B (hu) 2000-05-28
EP0517292B1 (fr) 2000-02-02
DK0517292T3 (da) 2000-05-08
PT517292E (pt) 2000-06-30
HU9201746D0 (en) 1992-08-28
JPH05244939A (ja) 1993-09-24
MX9202512A (es) 1995-01-31
BE1004877A3 (fr) 1993-02-16
DE69230627T2 (de) 2000-09-28
ES2145000T3 (es) 2000-07-01
IL101780A0 (en) 1992-12-30
CN1069068A (zh) 1993-02-17
BR9202024A (pt) 1993-01-19
NZ242620A (en) 1993-09-27
JP3411307B2 (ja) 2003-05-26
DE69230627D1 (de) 2000-03-09
IE921686A1 (en) 1992-12-02
AR248045A1 (es) 1995-05-31
KR100244601B1 (ko) 2000-03-02
CN1055501C (zh) 2000-08-16
KR920021706A (ko) 1992-12-18
SG49876A1 (en) 2002-04-16
AU1632392A (en) 1992-12-03

Similar Documents

Publication Publication Date Title
EP0517292B1 (fr) Virus de l'Avipox recombinant
EP0968297B1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
EP0719864B1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpès de dindes
EP0910657B1 (fr) Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2
EP0870046B1 (fr) Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
EP1151121B1 (fr) Vecteurs et vaccins viraux a base d'adenovirus porcins recombines
EP3041939B1 (en) Recombinant marek's disease viruses and uses thereof
FR2750866A1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
WO1998027215A1 (fr) Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
EP0728842B1 (fr) Vaccin vivant recombinant aviaire à base de virus herpès aviaire, notamment contre la maladie de gumboro
WO1998003659A1 (fr) Formule de vaccin polynucleotidique aviaire
WO1994000586A2 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
CA2709925A1 (fr) Vecteurs vaccinaux derives de leporipoxvirus

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued